Adamas Pharmaceuticals reported 10.1M in Trade Debtors for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Debtors Change
Acadia Pharmaceuticals ACAD:US $ 51.82M 5.57M
Acorda Therapeutics ACOR:US $ 14.01M 3.28M
Adamas Pharmaceuticals ADMS:US 10.1M 2.32M
Aerie Pharmaceuticals AERI:US $ 59.15M 13M
Aptinyx Inc APTX:US $ 0 0
Biocryst Pharmaceuticals BCRX:US $ 27.62M 9.23M
Flexion Therapeutics FLXN:US $ 35.23M 4.56M
Glaxosmithkline GSK:US $ 7507M 324M
GlaxoSmithKline GSK:LN 7.51B 324M
Gw Pharmaceuticals GWPH:US $ 84.95M 13.78M
Heron Therapeutics HRTX:US $ 42.62M 4.09M
Intra Cellular Therapies ITCI:US $ 15.19M 1.53M
Marinus Pharmaceuticals MRNS:US 4.2M 1.55M
Neurocrine Biosciences NBIX:US $ 158.5M 10.7M
Novartis NOVN:VX 8.65B 173M
Omeros OMER:US $ 31.84M 7.01M
Prothena PRTA:US 3K 2K
Revance Therapeutics RVNC:US $ 641K 4.54M
Teva Pharmaceutical TEVA:IT 4.49B 84M
Zogenix ZGNX:US $ 7.7M 1.58M